An Overview of Allowable Total Error in the Clinical Laboratory
Mar 13, 2026 - 11:53
Radio and PodcastLive Radio & PodcastsScience & Medicine
Rapid Whole-Genome Sequencing as a First-Line Test Is Likely to Significantly Reduce the Cost of Acute Care in a Private Payer System
Rapid Whole-Genome Sequencing as a First-Line Test Is Likely to Significantly Reduce the Cost of Acute Care in a Private Payer System is an episode from JALM Talk Podcast by American Association for Clinical Chemistry. T...
About This Episode
Rapid Whole-Genome Sequencing as a First-Line Test Is Likely to Significantly Reduce the Cost of Acute Care in a Private Payer System is an episode from JALM Talk Podcast by American Association for Clinical Chemistry. This science & medici...
Podcast
This episode belongs to JALM Talk Podcast.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Jul 24, 2025, 11:13 long, audio available.
Related Episodes
Continue listening to more episodes from JALM Talk Podcast.
Questions About This Episode
What is Rapid Whole-Genome Sequencing as a First-Line Test Is Likely to Significantly Reduce the Cost of Acute Care in a Private Payer System about?
Rapid Whole-Genome Sequencing as a First-Line Test Is Likely to Significantly Reduce the Cost of Acute Care in a Private Payer System is a podcast episode from JALM Talk Podcast. You can listen online and use the related episode section to continue with more content from the same show.
Where can I listen to Rapid Whole-Genome Sequencing as a First-Line Test Is Likely to Significantly Reduce the Cost of Acute Care in a Private Payer System?
You can listen to Rapid Whole-Genome Sequencing as a First-Line Test Is Likely to Significantly Reduce the Cost of Acute Care in a Private Payer System online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is Rapid Whole-Genome Sequencing as a First-Line Test Is Likely to Significantly Reduce the Cost of Acute Care in a Private Payer System from?
Rapid Whole-Genome Sequencing as a First-Line Test Is Likely to Significantly Reduce the Cost of Acute Care in a Private Payer System is an episode from JALM Talk Podcast by American Association for Clinical Chemistry.
How long is this episode?
This episode is 11:13 long.
When was this episode published?
This episode was published on Jul 24, 2025.
Can I save Rapid Whole-Genome Sequencing as a First-Line Test Is Likely to Significantly Reduce the Cost of Acute Care in a Private Payer System for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from JALM Talk Podcast?
Yes. This page shows related episodes from JALM Talk Podcast when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to Rapid Whole-Genome Sequencing as a First-Line Test Is Likely to Significantly Reduce the Cost of Acute Care in a Private Payer System?
You can listen to Rapid Whole-Genome Sequencing as a First-Line Test Is Likely to Significantly Reduce the Cost of Acute Care in a Private Payer System on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
Rapid Whole-Genome Sequencing as a First-Line Test Is Likely to Significantly Reduce the Cost of Acute Care in a Private Payer System is from JALM Talk Podcast by American Association for Clinical Chemistry.
What are the episode details?
Published Jul 24, 2025 and 11:13 long